1. Home
  2. VKTX vs FCN Comparison

VKTX vs FCN Comparison

Compare VKTX & FCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VKTX

Viking Therapeutics Inc.

N/A

Current Price

$27.05

Market Cap

4.0B

Sector

Health Care

ML Signal

N/A

Logo FTI Consulting Inc.

FCN

FTI Consulting Inc.

N/A

Current Price

$182.99

Market Cap

4.2B

ML Signal

N/A

Company Overview

Basic Information
Metric
VKTX
FCN
Founded
2012
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
4.2B
IPO Year
2014
1996

Fundamental Metrics

Financial Performance
Metric
VKTX
FCN
Price
$27.05
$182.99
Analyst Decision
Strong Buy
Buy
Analyst Count
21
3
Target Price
$95.32
★ $154.50
AVG Volume (30 Days)
★ 4.8M
376.7K
Earning Date
10-28-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 5.51
EPS
N/A
★ 6.22
Revenue
N/A
★ $3,788,857,000.00
Revenue This Year
N/A
$5.54
Revenue Next Year
N/A
$6.78
P/E Ratio
★ N/A
$28.88
Revenue Growth
N/A
★ 2.44
52 Week Low
$23.82
$129.12
52 Week High
$43.15
$189.30

Technical Indicators

Market Signals
Indicator
VKTX
FCN
Relative Strength Index (RSI) 46.50 81.18
Support Level $26.47 $151.05
Resistance Level $34.00 $188.00
Average True Range (ATR) 1.53 5.13
MACD 0.27 3.95
Stochastic Oscillator 70.21 95.15

Price Performance

Historical Comparison
VKTX
FCN

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About FCN FTI Consulting Inc.

FTI Consulting Inc is a firm that generates its sales by providing professional business advisory services to customers. The company operates through five segments, namely corporate finance, forensic and litigation consulting, economic consulting, technology, and strategic communications. The company generates the majority of its revenue from the Corporate finance segment. Customers of the company come from a wide array of sectors, including construction, energy and power, environmental, financial institutions, healthcare and life science, insurance, real estate and infrastructure, retail and consumer products, telecom, media, and technology. The majority of the company's revenue is derived from serving customers in the United States.

Share on Social Networks: